Skip to main content
Start of content

HESA Committee Meeting

Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at

Previous day publication Next day publication

Notice of meeting Amended

Standing Committee on Health (HESA)
42nd Parliament, 1st Session
Meeting No. 6
Wednesday, April 13, 2016, 3:30 p.m. to 5:30 p.m.

3:30 p.m. to 5:00 p.m.
Canadian Agency for Drugs and Technologies in Health
• Brian O'Rourke, President and Chief Executive Officer
Canadian Institute for Health Information
• Brent Diverty, Vice President of Programs
• Michael Gaucher, Director, Pharmaceuticals and Health Workforce Information Services
Department of Health
• Abby Hoffman, Assistant Deputy Minister, Strategic Policy Branch
• Scott Doidge, Director General, Non-Insured Health Benefits, First Nations and Inuit Health BranchAmended
• Frances Hall, Director, Office of Pharmaceuticals Management Strategies, Strategic Policy Branch
Patented Medicine Prices Review Board
• Tanya Potashnik, Director, Policy and Economic Analysis Branch
• Guillaume Couillard, Director, Board Secretariat, Communications and Strategic Planning

5:00 p.m. to 5:30 p.m.
(In Camera)
Clerk of the Committee
David Gagnon (613-995-4108)
2016/04/13 9:39 a.m.